Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. Nimbus Therapeutics and Eli Lilly announce their ...

Let there be light. Genesis Therapeutics has forged a $200 million venture capital round to help turn its artificial intelligence-powered pipeline toward human testing. First spun out of Stanford ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

The artificial intelligence-powered drug designer Atomwise has raised $123 million in venture capital funding, to both scale up its platform and its partnerships with large biopharma companies, and to ...

This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five ...

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 9, 2023) - PurMinds NeuroPharma ("PurMinds™" or the "Company"), a clinical-stage neuroscience company focused on neurological and ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

SCIENTIFIC PAPERS are normally models of discreet understatement. They are also (or are at least supposed to be) loaded with the information needed for others to replicate their findings. Not this one ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...